Organization | University of Dundee

University of Dundee Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Dundee Scotland United Kingdom (1967)

Organization Overview

First Clinical Trial

1996

NCT00002916

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

A. D. Struthers | Asthma and Allergy Research Group Division of Medicine and Therapeutics Ninewells Hospital and Medical School University of Dundee | Brian J Lipworth | Centre for Cadiovascular Medicine, University of Dundee | Evan Pearson | NHS Tayside | Ninewells Hospital | Ninewells Hospital and Medical School, Ninewells, Dundee, UK | Ninewells Hospital Dundee | Ninewells Hospital & Medical School | Ninewells Hospital, University of Dundee, Scotland, UK | Stephen McSwiggan | Tayside Children's Hospital | University of Dundee | University of Dundee / NHS Tayside | University of Dundee, Scotland | University of Dundee, UK

Active Ingredients

Drugs in Phase 4 Trials (58)

aclidinium (tudorza pressair) (2 trials)

adalimumab (humira) (1 trial)

albuterol (proventil) (2 trials)

allopurinol (zyloprim) (7 trials)

alpha-1 antitrypsin (Prolastin) (1 trial)

amiloride (midamor) (1 trial)

atorvastatin (lipitor) (1 trial)

azelastine (astelin) (2 trials)

beclomethasone (vanceril) (6 trials)

bisoprolol (zebeta) (2 trials)

budesonide (rhinocort) (3 trials)

canagliflozin (invokana) (1 trial)

carvedilol (coreg) (1 trial)

celecoxib (celebrex) (1 trial)

celiprolol (1 trial)

dapagliflozin (farxiga) (2 trials)

diazoxide (hyperstat) (1 trial)

diclofenac (voltaren) (1 trial)

doxazosin (cardura) (1 trial)

empagliflozin (jardiance) (1 trial)

etanercept (enbrel) (1 trial)

fenofibrate (fenoglide) (1 trial)

fluticasone (cutivate) (15 trials)

formoterol (foradil) (5 trials)

furosemide (lasix) (1 trial)

gliclazide (4 trials)

glycopyrronium (robinul) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

ibuprofen (motrin) (1 trial)

icosapent ethyl (vascepa) (2 trials)

indacaterol (arcapta neohaler) (1 trial)

invokana (1 trial)

lactose (1 trial)

levalbuterol (xopenex) (2 trials)

levobupivacaine (chirocaine) (2 trials)

levocetirizine (xyzal) (1 trial)

lisdexamfetamine (vyvanse) (1 trial)

meloxicam (mobic) (1 trial)

menthol (Salonpas) (1 trial)

metformin (glucophage) (1 trial)

naproxen (naprosyn) (1 trial)

olodaterol (striverdi respimat) (2 trials)

omeprazole (prilosec) (2 trials)

oxymetazoline (ocuclear) (2 trials)

pioglitazone (actos) (4 trials)

prazosin (minipress) (1 trial)

prednisone (meticorten) (1 trial)

propranolol (inderal) (3 trials)

rituximab (rituxan) (1 trial)

ropivacaine (naropin) (1 trial)

salmeterol (serevent) (5 trials)

sitagliptin (januvia) (10 trials)

sodium chloride (2 trials)

sodium iodide (1 trial)

spironolactone (aldactone) (1 trial)

tiotropium (spiriva) (6 trials)

urea (2 trials)

vilanterol (Anoro Elipta) (2 trials)

Drugs in Phase 3 Trials (12)

azd7986 (1 trial)

buprenorphine (1 trial)

calcipotriene (dovonex) (2 trials)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

methadone (methadose) (1 trial)

miglyol oil (1 trial)

rosuvastatin (crestor) (1 trial)

saxagliptin (onglyza) (1 trial)

tacalcitol (1 trial)

tezepelumab (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (11)

aztreonam (azactam) (1 trial)

betamethasone (celestone) (1 trial)

bisoctyltriazole (1 trial)

elbasvir (1 trial)

grazoprevir (zepatier) (1 trial)

human papillomavirus 16 e7 peptide (1 trial)

sofosbuvir (sovaldi) (1 trial)

synthetic human papillomavirus 16 e6 peptide (1 trial)

tadalafil (cialis) (1 trial)

titanium oxide (1 trial)

tobramycin (nebcin) (2 trials)

Drugs in Phase 1 Trials (1)

autologous mesenchymal stem cell-derived neural progenitors (1 trial)

Drugs in Other Trials (32)

avobenzone (shade uvaguard) (1 trial)

bifidobacterium longum (2 trials)

ceftazidime (fortaz) (1 trial)

cefuroxime (zinacef) (1 trial)

ciprofloxacin (cipro) (1 trial)

clarithromycin (biaxin) (1 trial)

clavulanate (Augmentin) (1 trial)

doxycycline (vibramycin) (1 trial)

drometrizole (1 trial)

exenatide (byetta) (1 trial)

fiber (1 trial)

inulin (2 trials)

kemester (1 trial)

letrozole (femara) (1 trial)

liraglutide (victoza) (1 trial)

lithium (lithonate) (1 trial)

methylbenzylidene camphor (1 trial)

metronidazole (flagyl) (1 trial)

montelukast (singulair) (1 trial)

neomycin (1 trial)

octinoxate (1 trial)

octocrylene (1 trial)

octyl salicylate (1 trial)

phenylbenzimidazolesulfonic acid (1 trial)

phenyl ketone (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

resistant starch (1 trial)

rifaximin (xifaxan) (1 trial)

sufonylurea (1 trial)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

vancomycin (Vancocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 4)

Angina, Stable (Phase 4)

Arrhythmias, Cardiac (Phase 4)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 4)

Ataxia (Phase 4)

Ataxia Telangiectasia (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Bronchiectasis (Phase 2)

Cerebellar Ataxia (Phase 4)

Chronic Disease (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Retinopathy (Phase 4)

Fibrosis (Phase 2)

Heart Failure (Phase 4)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hyperkinesis (Phase 4)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 2)

Hypertrophy (Phase 4)

Hypertrophy, Left Ventricular (Phase 4)

Hypoglycemia (Phase 4)

Infections (Phase 2)

Inflammation (Phase 4)

Insulin Resistance (Phase 4)

Ischemia (Phase 1)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Microvascular Angina (Phase 4)

Myocardial Ischemia (Phase 4)

Nasal Polyps (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Prediabetic State (Phase 4)

Premature Birth (Phase 4)

Psoriasis (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Rectal Neoplasms (Phase 3)

Renal Insufficiency (Phase 4)

Respiratory Aspiration (Phase 2)

Respiratory Hypersensitivity (Phase 2)

Retinal Diseases (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Sarcopenia (Phase 4)

Syndrome (Phase 4)

Telangiectasis (Phase 4)

Urticaria (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Ventricular Remodeling (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 97
# of Trial APIs: 114